Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 2Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 5Wilms Tumor 3Kidney Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 2Gestational Trophoblastic Disease 2Neoplasms 1Malignant mesenchymal tumor 1

Interventions

Vincristine 2Radiotherapy 2Melphalan 2Ifosfamide 2Etoposide 2Doxorubicin 2Dactinomycin 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1aldesleukin 1Methylprednisolone 1Mesna 1Magnetic Resonance Spectroscopy 1Gene Expression Profiling 1Gelclair 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neuroectodermal Tumors, Primitive, Peripheral × Dactinomycin × Clear all
NCT00020566 2014-06-24

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
1,200 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00002516 2013-09-17

Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡